Drug Type Small molecule drug |
Synonyms- |
Mechanism SCNA modulators(Sodium channel alpha subunit modulators), β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC13H19Br2ClN2O |
InChIKeyQNVKOSLOVOTXKF-PFWPSKEQSA-N |
CAS Registry23828-92-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Phase 3 | CN | - | 20 Nov 2013 |
Pulmonary Disease, Chronic Obstructive | Phase 2 | CN | 09 Jan 2015 | |
Acute Bronchitis | Phase 1 | CN | - | 14 Jun 2014 |
Asthmatic bronchitis | Phase 1 | CN | - | 14 Jun 2014 |
Bronchial Spasm | Phase 1 | CN | - | 14 Jun 2014 |
Bronchitis, Chronic | Phase 1 | CN | - | 14 Jun 2014 |
Asthma | Preclinical | CN | 20 Nov 2013 |